Skip to main content

Table 3 Participant characteristics: overall, characteristics were generally well balanced across the treatment groups

From: Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)

   Randomized to leukodepletion
filter (n = 32)
Randomized to standard
Filter (n = 31)
Overall
(n = 63)
n % n % n %
Age (years) Median (IQR) 73.5 (69.6, 77.9) 72.0 (61.5, 76.9) 72.6 (66.1, 77.7)
Male   21/32 66% 18/31 58% 39/63 62%
Black ethnicity   2/32 6% 0/31 0% 2/63 3%
BMI Median (IQR) 27.0 (24.4, 32.3) 29.7 (26.0, 34.6) 27.8 (25.5, 33.3)
EuroSCORE Median (IQR) 6.0 (5.0, 7.0) 6.0 (3.0, 7.0) 6.0 (4.0, 7.0)
Cleveland CSA-AKI score Median (IQR) 2.0 (1.0, 3.0) 2.0 (2.0, 3.0) 2.0 (1.0, 3.0)
ECHO/ANGIOGRAM REPORT
 LV function Good (> 50%) 28/32 88% 26/31 84% 54/63 86%
Moderate (30–50%) 4/32 13% 5/31 16% 9/63 14%
 Extent of coronary disease None/not investigated 22/32 69% 20/31 64% 42/63 66%
Single 2/32 6% 5/31 16% 7/63 11%
Double 3/32 9% 4/31 13% 7/63 11%
Triple 5/32 16% 2/31 6% 7/63 11%
 > 50% disease in left main stem   2/32 6% 2/31 6% 4/63 6%